The Role of Diabetes in Acromegaly Associated Neoplasia

por Cheng, Sonia, Gomez, Karen, Serri, Omar, Chik, Constance, Ezzat, Shereen
Publicado 2015

Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly

por Cheng, Sonia, Al-Agha, Rany, Araujo, Paula B., Serri, Omar, L. Asa, Sylvia, Ezzat, Shereen
Publicado 2013

Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multic...

por Sheppard, Michael, Bronstein, Marcello D., Freda, Pamela, Serri, Omar, De Marinis, Laura, Naves, Luciana, Rozhinskaya, Liudmila, Hermosillo Reséndiz, Karina, Ruffin, Matthieu, Chen, YinMiao, Colao, Annamaria
Publicado 2014

Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-b...

por Sheppard, Michael, Bronstein, Marcello D., Freda, Pamela, Serri, Omar, De Marinis, Laura, Naves, Luciana, Rozhinskaya, Liudmila, Hermosillo Reséndiz, Karina, Ruffin, Matthieu, Chen, YinMiao, Colao, Annamaria
Publicado 2015